Best Evidence Summary for the Prevention of Ventilator-Associated Pneumonia Authors: Wenjuan Wu, Yuanxin Pan, Xiang An, Jiamin Lyu Published: 2026 ABSTRACT ObjectiveTo retrieve, appraise, and synthesize the best available evidence on the prevention of ventilator-associated pneumonia (VAP) from Chinese and international sources, and to provide evidence-based guidance for clinical nursing practice.MethodsGuided by the 6S evidence pyramid model, a comprehensive electronic search was conducted in BMJ Best Practice, UpToDate, the Guidelines International Network, the National Institute for Health and Care Excellence, the Scottish Intercollegiate Guidelines Network, the Registered Nurses’ Association of Ontario, the American Association for Respiratory Care, the American Thoracic Society, CHEST, the Cochrane Library, the IBI Evidence-Based Health Care Center database, Embase, PubMed, Medlive, the Chinese Thoracic Society, the Chinese Biomedical Literature Database, China National Knowledge Infrastructure, and Wanfang Database. The search period ranged from January 1, 2016, to January 1, 2026. Evidence summaries, clinical practice guidelines, systematic reviews, and other evidence-based resources related to VAP prevention were retrieved. After quality appraisal and evidence synthesis, the best evidence was summarized.ResultsA total of 24 publications were included, comprising 2 clinical decision support resources, 10 systematic reviews, 5 guidelines, and 7 evidence summaries. Thirty-three recommendations were synthesized into eight practical domains covering organizational strategies, prevention bundles, airway management, positioning, nutrition, device management, pharmacologic approaches, and non-recommended interventions.ConclusionThis evidence summary systematically synthesizes the best available evidence regarding VAP prevention and provides evidence-based guidance for standardized clinical management. These findings may support clinical decision-making and the development of nursing practice strategies for VAP prevention; however, further studies are needed to evaluate the effectiveness of implementing these recommendations in specific clinical settings. Introduction Ventilator-associated pneumonia (VAP) is defined as pneumonia that develops more than 48 hours after endotracheal intubation or tracheostomy in patients receiving mechanical ventilation. Pneumonia occurring within 48 hours after ventilator weaning or extubation is also considered within the spectrum of VAP.1 VAP is among the most common infections in patients undergoing mechanical ventilation. According to the National Healthcare Safety Network (NHSN) of the US Centers for Disease Control and Prevention (CDC), the median incidence of VAP in medical-surgical intensive care units (ICUs) in the United States is 1.1 cases per 1000 ventilator-days.2 In contrast, the International Nosocomial Infection Control Consortium (INICC) has reported persistently higher VAP rates in low- and middle-income countries (LMICs) over the past 2 decades. The reported VAP rate decreased from 24.1 cases per 1000 ventilator-days during 2002–2005 to 11.96 cases per 1000 ventilator-days during 2015–2020,3 but it remained substantially higher than the CDC/NHSN estimate. These data underscore the need to evaluate and strengthen preventive strategies, particularly in LMICs. VAP is the second most common health care–associated infection (HAI) in pediatric ICUs. Critically ill children are at increased risk because of immature immune function and prolonged exposure to mechanical ventilation. The economic burden of VAP varies across settings, with reported attributable costs of 9,966 US dollars4 in the United States and 20,965.28 euros in Spain5 A study including data from 630 ICUs in 45 LMICs across Africa, Asia, Eastern Europe, Latin America, and the Middle East from 2015 to 2020 included 204,770 patients 1,480,620 patient-days, 637,850 ventilator-days, and 7635 VAP cases. Among patients without HAIs, the length of stay was 6.57 days and mortality was 14.06%; among patients with VAP, the length of stay increased to 22.54 days and mortality reached 36.89%.3 VAP prolongs mechanical ventilation and hospitalization, increases antimicrobial use and hospital costs, and is associated with increased morbidity and mortality, thereby adversely affecting outcomes in critically ill patients.1 Although several international and national guidelines and reviews have addressed VAP prevention, existing recommendations vary in scope, evidence sources, and clinical implementation strategies. Many guidelines primarily provide broad recommendations, whereas evidence from systematic reviews, evidence summaries, and clinical decision support resources remains dispersed and requires further integration for bedside application. In addition, updates in preventive strategies, particularly those involving nursing procedures, multidisciplinary collaboration, and implementation approaches, require continuous evidence synthesis. Therefore, this evidence summary aimed not to replace existing guidelines but to integrate and appraise the most recent high-level evidence from multiple sources, including clinical decision support resources, guidelines, systematic reviews, and evidence summaries. By translating heterogeneous evidence into structured and actionable recommendations, this study seeks to provide a practical evidence framework to support standardized nursing practice and clinical decision-making for VAP prevention. Methods Eligibility Criteria Studies were eligible for inclusion if they met the following criteria: the study population consisted of adult patients receiving mechanical ventilation; the content addressed preventive measures for ventilator-associated pneumonia (VAP); the publication type was an evidence summary, guideline, systematic review, or expert consensus; and the publication language was Chinese or English. Studies were excluded if they were direct translations or duplicate publications, if the full text was unavailable, or if they failed to meet the quality appraisal criteria. Evidence Search Strategy Evidence-based questions were formulated according to the PIPOST model proposed by the Fudan University JBI Evidence-Based Nursing Center.6 In this model, the first P, population, referred to the target population for clinical translation of evidence: adult patients receiving mechanical ventilation. I, intervention, referred to preventive measures for VAP. The second P, professional, referred to the professionals responsible for clinical translation of evidence: intensive care physicians and nurses. O, outcome, referred to a reduction in the incidence of VAP. S, setting, referred to the clinical setting for evidence translation: intensive care units. T, type of evidence, referred to the type of evidence resources: clinical decision support resources, evidence summaries, guidelines, systematic reviews, and expert consensus statements. According to the 6S evidence pyramid model,7 computerized decision support systems, topic-based evidence summaries, synopses of systematic reviews or evidence-based summaries, and systematic reviews or evidence syntheses were searched sequentially from the highest to the lower levels of evidence. The search strategy was based on the following terms: “Pneumonia, Ventilator-Associated” or “ventilator-associated pneumonia,” combined with “prevention,” “guideline,” “meta-analysis,” and “systematic review.” The following databases and websites were searched: BMJ Best Practice, UpToDate, Guidelines International Network, National Institute for Health and Care Excellence, Scottish Intercollegiate Guidelines Network, Registered Nurses’ Association of Ontario, American Association for Respiratory Care, American Thoracic Society, CHEST, Cochrane Library, JBI Evidence-Based Health Care Center database, Embase, PubMed, Medlive, Chinese Thoracic Society, Chinese Biomedical Literature Database, China National Knowledge Infrastructure, and Wanfang Database. The search period was from January 1, 2016, to January 1, 2026. Evidence related to VAP prevention was systematically retrieved. Using PubMed as an Example, the Search Strategy Was as Follows: #1 “pneumonia, ventilator-associated”[MeSH Terms] #2 “ventilator-associated pneumonia”[Title/Abstract] OR “pneumonia, ventilator-associated”[MeSH Terms] #3 “ventilator-associated pneumonia”[Title/Abstract] OR “pneumonia, ventilator-associated”[MeSH Terms] AND guideline[Filter] OR meta-analysis[Filter] OR practice guideline[Filter] OR systematic review[Filter] AND 2016:2026[pdat] Quality Appraisal Criteria For evidence summaries, the original studies corresponding to the cited evidence were traced, and the appropriate appraisal tools from the JBI Evidence-Based Health Care Center in Australia were selected according to the study design. Guidelines were appraised using the Appraisal of Guidelines for Research and Evaluation II (AGREE II) instrument.8 Systematic reviews, expert consensus statements, and randomized clinical trials were appraised using the 2016 JBI critical appraisal tools for systematic reviews, expert consensus statements, and randomized clinical trials, respectively.9 Quality Appraisal Process Three reviewers independently conducted literature screening, methodological quality appraisal, evidence extraction, and evidence grading. Each reviewer completed the evaluation independently using predefined criteria and the appropriate appraisal tools according to evidence type. Disagreements were discussed among the reviewers until consensus was achieved. When consensus could not be reached, a fourth reviewer participated in the discussion and made the final decision. Because this study synthesized multiple types of evidence resources, including guidelines, systematic reviews, clinical decision support resources, and evidence summaries, different appraisal instruments were applied according to study type. Therefore, Cohen’s kappa coefficient was not calculated; instead, agreement was ensured through independent assessment and consensus procedures. Evidence Extraction and Synthesis The JBI evidence pregrading system developed by the JBI Evidence-Based Health Care Center in Australia in 2014 was used to preliminarily grade the included evidence.10 The research team jointly discussed, confirmed, and graded the extracted evidence. When conclusions differed across evidence sources, the following principles were applied: priority was given to evidence-based evidence, higher-quality evidence, more recently published evidence, and international guidelines. Given the heterogeneity of included evidence resources, including different study designs, interventions, outcomes, and methodological frameworks, quantitative statistical pooling was not performed. Instead, evidence was synthesized using a descriptive narrative approach. Publication bias was not assessed using statistical methods because this study did not conduct meta-analysis or generate pooled effect estimates. No subgroup analyses were conducted because this study aimed to synthesize and translate the best available evidence rather than compare intervention effects among different patient populations or intervention subgroups. Results Study Selection A total of 1511 records were initially identified. After duplicate records were removed and titles, abstracts, and full texts were screened according to the predefined eligibility criteria, 24 publications were ultimately included. Among these, 2 were clinical decision support resources, 10 were systematic reviews, 5 were guidelines, and 7 were evidence summaries. The study selection process and results are shown in Figure 1.Figure 1Flow Diagram of Literature Screening.A flowchart of literature screening from 1511 records to 24 included studies. Flow Diagram of Literature Screening. Characteristics of Included Publications Among the 24 included publications, 2 were clinical decision support resources, 10 were systematic reviews, 5 were guidelines, and 7 were evidence summaries. The general characteristics of the included publications are presented in Table 1. Table 1General Characteristics of the Included PublicationsNo.DatabaseAuthorTopicTypeYear1UpToDateMichael Klompas et al11Risk Factors and Prevention of Hospital-Acquired and Ventilator-Associated Pneumonia in AdultsClinical decision support20252UpToDateMarin H Kollef et al12Clinical Presentation and Diagnostic Evaluation of Ventilator-Associated PneumoniaClinical decision support20253PubMedD Zhu et al13Efficacy of Preventive Interventions Against Ventilator-Associated Pneumonia in Critically Ill PatientsSystematic review20244BMJBurns KEA et al14Noninvasive Ventilation vs Invasive Weaning in Critically Ill Adults: A Systematic Review and Meta-analysisSystematic review20225PubMedWang X et al15Impact of Abdominal Massage on Enteral Nutrition Complications in Adult Critically Ill Patients: A Systematic ReviewSystematic review20226PubMedXiuqiu Zhuo et al16Oral Hygiene Care for Critically Ill Patients to Prevent Ventilator-Associated PneumoniaSystematic review20217PubMedAna et al17Efficiency of Different Oral Hygiene Protocols Combined With Chlorhexidine Use for the Prevention of Ventilator-Associated PneumoniaSystematic review20218PubMedTing Ji et al18Preventive Effect of Probiotics on Ventilator-Associated Pneumonia: A Meta-analysis of 2428 PatientsSystematic review20219PubMedShiqi Liang et al19Association Between Perioperative Chlorhexidine Oral Care and Postoperative Pneumonia in Noncardiac Surgical Patients: A Systematic Review and Meta-analysisSystematic review202110PubMedMinami et al20Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-analysis of Randomized Clinical TrialsSystematic review202111PubMedKevin et al21Association of Early vs Late Tracheostomy Placement With Pneumonia and Ventilator Days in Critically Ill Patients: A Meta-analysisSystematic review202112Wanfang DatabaseHuang Huimin et al22Efficacy of Closed vs Open Tracheal Suction Systems for Prevention of Ventilator-Associated Pneumonia: A Meta-analysisSystematic review202113NICEKimberley Carter et al23PneuX to Prevent Ventilator-Associated PneumoniaGuideline202514ISIDRosenthal VD24Preventing Ventilator-Associated Pneumonia: A Position Paper of the International Society for Infectious Diseases, 2024 UpdateGuideline202415PubMedKlompas M et al25Strategies to Prevent Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nonventilator Hospital-Acquired Pneumonia in Acute Care Hospitals: 2022 UpdateGuideline202216MedliveInfection Group, Chinese Thoracic Society26Chinese Guidelines for the Diagnosis and Treatment of Adult Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: 2018 EditionGuideline201817PubMedERS/ESICM/ESCMID/ALAT27International ERS/ESICM/ESCMID/ALAT Guidelines for the Management of Hospital-Acquired Pneumonia and Ventilator-Associated PneumoniaGuideline201718JBIEric et al28Evidence Summary: Oral Care—Foam Swabs/Foam SpongesEvidence summary202119JBICynthia et al29Evidence Summary: Ventilator-Associated Pneumonia—Techniques to Obtain Clinical SamplesEvidence summary202120JBIFaith et al30Evidence Summary: Oral Hygiene Care—Critically Ill PatientsEvidence summary202121JBIMadhava et al31Evidence Summary: Ventilator-Associated Pneumonia—Duration of Antibiotic TreatmentEvidence summary202122JBILauren et al32Ventilator-Associated Pneumonia: Strategies to Improve Compliance With Standards of CareEvidence summary202123CNKIWang Wenjing et al33Evidence Summary of Guidelines for the Prevention of Ventilator-Associated PneumoniaEvidence summary202024CNKIShan Jun et al34Best Evidence Summary for Prevention Strategies for Methicillin-Resistant Staphylococcus aureus Ventilator-Associated PneumoniaEvidence summary2019 Table 1General Characteristics of the Included PublicationsNo.DatabaseAuthorTopicTypeYear1UpToDateMichael Klompas et al11Risk Factors and Prevention of Hospital-Acquired and Ventilator-Associated Pneumonia in AdultsClinical decision support20252UpToDateMarin H Kollef et al12Clinical Presentation and Diagnostic Evaluation of Ventilator-Associated PneumoniaClinical decision support20253PubMedD Zhu et al13Efficacy of Preventive Interventions Against Ventilator-Associated Pneumonia in Critically Ill PatientsSystematic review20244BMJBurns KEA et al14Noninvasive Ventilation vs Invasive Weaning in Critically Ill Adults: A Systematic Review and Meta-analysisSystematic review20225PubMedWang X et al15Impact of Abdominal Massage on Enteral Nutrition Complications in Adult Critically Ill Patients: A Systematic ReviewSystematic review20226PubMedXiuqiu Zhuo et al16Oral Hygiene Care for Critically Ill Patients to Prevent Ventilator-Associated PneumoniaSystematic review20217PubMedAna et al17Efficiency of Different Oral Hygiene Protocols Combined With Chlorhexidine Use for the Prevention of Ventilator-Associated PneumoniaSystematic review20218PubMedTing Ji et al18Preventive Effect of Probiotics on Ventilator-Associated Pneumonia: A Meta-analysis of 2428 PatientsSystematic review20219PubMedShiqi Liang et al19Association Between Perioperative Chlorhexidine Oral Care and Postoperative Pneumonia in Noncardiac Surgical Patients: A Systematic Review and Meta-analysisSystematic review202110PubMedMinami et al20Probiotics for the Prevention of Ventilator-Associated Pneumonia: A Meta-analysis of Randomized Clinical TrialsSystematic review202111PubMedKevin et al21Association of Early vs Late Tracheostomy Placement With Pneumonia and Ventilator Days in Critically Ill Patients: A Meta-analysisSystematic review202112Wanfang DatabaseHuang Huimin et al22Efficacy of Closed vs Open Tracheal Suction Systems for Prevention of Ventilator-Associated Pneumonia: A Meta-analysisSystematic review202113NICEKimberley Carter et al23PneuX to Prevent Ventilator-Associated PneumoniaGuideline202514ISIDRosenthal VD24Preventing Ventilator-Associated Pneumonia: A Position Paper of the International Society for Infectious Diseases, 2024 UpdateGuideline202415PubMedKlompas M et al25Strategies to Prevent Ventilator-Associated Pneumonia, Ventilator-Associated Events, and Nonventilator Hospital-Acquired Pneumonia in Acute Care Hospitals: 2022 UpdateGuideline202216MedliveInfection Group, Chinese Thoracic Society26Chinese Guidelines for the Diagnosis and Treatment of Adult Hospital-Acquired Pneumonia and Ventilator-Associated Pneumonia: 2018 EditionGuideline201817PubMedERS/ESICM/ESCMID/ALAT27International ERS/ESICM/ESCMID/ALAT Guidelines for the Management of Hospital-Acquired Pneumonia and Ventilator-Associated PneumoniaGuideline201718JBIEric et al28Evidence Summary: Oral Care—Foam Swabs/Foam SpongesEvidence summary202119JBICynthia et al29Evidence Summary: Ventilator-Associated Pneumonia—Techniques to Obtain Clinical SamplesEvidence summary202120JBIFaith et al30Evidence Summary: Oral Hygiene Care—Critically Ill PatientsEvidence summary202121JBIMadhava et al31Evidence Summary: Ventilator-Associated Pneumonia—Duration of Antibiotic TreatmentEvidence summary202122JBILauren et al32Ventilator-Associated Pneumonia: Strategies to Improve Compliance With Standards of CareEvidence summary202123CNKIWang Wenjing et al33Evidence Summary of Guidelines for the Prevention of Ventilator-Associated PneumoniaEvidence summary202024CNKIShan Jun et al34Best Evidence Summary for Prevention Strategies for Methicillin-Resistant Staphylococcus aureus Ventilator-Associated PneumoniaEvidence summary2019 General Characteristics of the Included Publications Quality Appraisal of Included Publications Five guidelines were included in this review. The standardized percentages for each AGREE II domain and the mean overall appraisal scores are shown in Table 2. Ten systematic reviews were included.13–22 According to the 2016 JBI critical appraisal checklist for systematic reviews, all appraisal items were rated as “yes,” except item 9, which assessed whether the likelihood of publication bias had been evaluated and was rated as “no.” Overall, the 10 systematic reviews were considered to be of high methodological quality and were included in the evidence synthesis. Two clinical decision support resources11,12 and 7 evidence summaries28–34 were also included. The original studies supporting the cited evidence were traced and appraised using the corresponding critical appraisal tools. Overall, these sources were judged to be of high quality. Table 2Quality Appraisal Results of Included Guidelines Using AGREE IIIncluded GuidelineScope and Purpose, %Stakeholder Involvement, %Rigor of Development, %Clarity of Presentation, %Applicability, %Editorial Independence, %No. of Domains ≥60%No. of Domains ≥30%Recommendation GradeKimberley Carter et al2397.2283.3386.4675.0077.0891.6766ARosenthal VD et al2491.6769.4467.7072.2268.7587.5066AKlompas M et al2574.0068.2994.3779.7369.4691.7066AChinese Thoracic Society Infection Group2688.8966.6754.1772.2266.6779.1756BERS/ESICM/ESCMID/ALAT2797.2286.1180.2075.0062.5083.3366A Table 2Quality Appraisal Results of Included Guidelines Using AGREE IIIncluded GuidelineScope and Purpose, %Stakeholder Involvement, %Rigor of Development, %Clarity of Presentation, %Applicability, %Editorial Independence, %No. of Domains ≥60%No. of Domains ≥30%Recommendation GradeKimberley Carter et al2397.2283.3386.4675.0077.0891.6766ARosenthal VD et al2491.6769.4467.7072.2268.7587.5066AKlompas M et al2574.0068.2994.3779.7369.4691.7066AChinese Thoracic Society Infection Group2688.8966.6754.1772.2266.6779.1756BERS/ESICM/ESCMID/ALAT2797.2286.1180.2075.0062.5083.3366A Quality Appraisal Results of Included Guidelines Using AGREE II Evidence Summary Evidence on the prevention of ventilator-associated pneumonia was synthesized and categorized into 8 domains: organizational support and surveillance, bundle-based strategies and education and training, airway management procedures, positioning and mobilization, nutrition and feeding, device and equipment management, pharmacologic prophylaxis and decontamination, and interventions explicitly not recommended. A total of 33 actionable evidence statements were extracted. Details are provided in Table 3. Table 3Summary of Best Evidence for the Prevention of Ventilator-Associated PneumoniaDomainEvidenceLevel of EvidenceOrganizational Support and Surveillance1. Clinical departments using ventilators should incorporate VAP prevention and control into medical quality and safety management, clearly define staff responsibilities, and develop and implement rules, regulations, and standard operating procedures24,272b2. Adequate full-time infection prevention and control personnel should be allocated to conduct VAP case surveillance, collect ventilator-day data, report data, and audit adherence24,263c3. Targeted surveillance of VAP should be conducted, and surveillance data should be regularly analyzed, summarized, and fed back25,26,332b4. Adherence to VAP prevention and control measures should be regularly monitored and fed back to support continuous quality improvement24,25,322b5. Effective laboratory support should be ensured, with timely specimen processing and reporting of results. Isolation precautions should be implemented for patients with VAP infection or colonization caused by multidrug-resistant organisms12,25,27,342bBundle-Based Strategies and Education and Training6. A structured VAP prevention bundle should be implemented as an integrated quality improvement strategy. The bundle should include evidence-based interventions targeting major VAP risk factors, with implementation supported by standardized protocols, multidisciplinary collaboration, and regular compliance monitoring13,24,27,331a7. Multiple preventive and control measures should be combined and implemented simultaneously as a bundle strategy24,25,322b8. Regular education and competency-based training programs should be developed for healthcare personnel involved in mechanical ventilation care. Training content should be updated according to emerging evidence and local epidemiological characteristics, and effectiveness should be evaluated through feedback and quality improvement processes24,262b9. Health care personnel in clinical departments using ventilators should receive professional training in ventilator operation and infection prevention and control25,262bAirway Management Procedures10. Healthcare personnel should adhere strictly to hand hygiene standards before and after ventilator-related procedures, including appropriate handwashing and hand antisepsis techniques, to reduce the risk of pathogen transmission24,262b11. Oral hygiene should be performed regularly, once every 6 to 8 hours16,28,302b12. Toothbrushing combined with rinsing is recommended for oral care in patients receiving mechanical ventilation; chlorhexidine solution should not be used routinely16,17,19,28,301a13. An endotracheal tube of appropriate size should be selected, and cuff pressure should be monitored and maintained at 25 to 30 cm H2O23,272b14. Continuous cuff pressure control devices should be used in combination with subglottic secretion drainage23,271a15. For patients expected to require endotracheal intubation for more than 72 hours, an endotracheal tube with subglottic secretion drainage should be selected23,25,272b16. Airway secretions should be suctioned promptly during patient transport, changes in body position or tube position, or accumulation of airway secretions, and aseptic technique should be followed12,25,292b17. Closed suction catheters are preferred for patients with infection or colonization caused by multidrug-resistant pathogens and for patients with suspected or confirmed respiratory infectious diseases22,26,342b18. Heated humidifiers or heat and moisture exchangers should be used in ventilator circuits. Continuous infusion of humidifying fluid by microinfusion pump should not be used for humidification, and sterile water should be used in heated humidifiers25,272b19. Water traps in ventilator circuits should be placed at the lowest point of the circuit, and the circuit should remain closed when condensate is removed. Condensate in the water trap should be removed before the patient is turned or repositioned25,26,332b20. For patients with suspected or confirmed respiratory infectious diseases, bacterial filters may be used at the expiratory limb of the ventilator to prevent contamination of internal tubing25,272bPositioning and Mobilization21. In the absence of contraindications, the head of the bed should be elevated to 30° to 45°13,25,27,332b22. Early mobilization should be encouraged and assisted in patients receiving mechanical ventilation, and rehabilitation training should be initiated as early as possible13,25,271cNutrition and Feeding23. When enteral nutrition is provided, the feeding route should be selected based on individualized assessment of aspiration risk, gastrointestinal function, expected duration of enteral feeding, and clinical feasibility11,15,18,332b24. Routine monitoring of gastric residual volume is not recommended for asymptomatic patients receiving enteral nutrition15,271c25. Routine stress ulcer prophylaxis is not recommended15,171aDevice and Equipment Management26. Indications for endotracheal intubation should be strictly assessed. Noninvasive ventilation should be preferred when appropriate. Oral endotracheal intubation is preferred, whereas nasal intubation is not recommended11,14,25,262b27. The need for continued mechanical ventilation and endotracheal intubation should be assessed daily, and weaning or extubation should be performed as early as possible11,252b28. Ventilator circuits should not be changed routinely or frequently in patients receiving continuous mechanical ventilation; circuits should be replaced promptly when contaminated or malfunctioning25,272b29. Heat and moisture exchangers should be replaced every 5 to 7 days and should be replaced promptly when contaminated or when airway resistance increases24,252b30. Reusable external ventilator circuits and accessories should be used for only 1 patient and disinfected after each use. For long-term use, they should be replaced weekly and centrally cleaned and disinfected by the central sterile supply department25,26,342b31. The ventilator exterior, buttons, panels, and other surfaces in use should be wiped and disinfected at least twice daily and immediately when contaminated. The frequency should be increased for patients with infection or colonization caused by multidrug-resistant organisms25,342bPharmacologic Prophylaxis and Decontamination32. Systemic or topical respiratory antimicrobial agents should be avoided for VAP prevention. Routine oral antimicrobial administration for selective digestive tract decontamination is not recommended13,18,20,27,312b33. For patients receiving sedatives, discontinuation or dose reduction should be assessed daily11,252b Table 3Summary of Best Evidence for the Prevention of Ventilator-Associated PneumoniaDomainEvidenceLevel of EvidenceOrganizational Support and Surveillance1. Clinical departments using ventilators should incorporate VAP prevention and control into medical quality and safety management, clearly define staff responsibilities, and develop and implement rules, regulations, and standard operating procedures24,272b2. Adequate full-time infection prevention and control personnel should be allocated to conduct VAP case surveillance, collect ventilator-day data, report data, and audit adherence24,263c3. Targeted surveillance of VAP should be conducted, and surveillance data should be regularly analyzed, summarized, and fed back25,26,332b4. Adherence to VAP prevention and control measures should be regularly monitored and fed back to support continuous quality improvement24,25,322b5. Effective laboratory support should be ensured, with timely specimen processing and reporting of results. Isolation precautions should be implemented for patients with VAP infection or colonization caused by multidrug-resistant organisms12,25,27,342bBundle-Based Strategies and Education and Training6. A structured VAP prevention bundle should be implemented as an integrated quality improvement strategy. The bundle should include evidence-based interventions targeting major VAP risk factors, with implementation supported by standardized protocols, multidisciplinary collaboration, and regular compliance monitoring13,24,27,331a7. Multiple preventive and control measures should be combined and implemented simultaneously as a bundle strategy24,25,322b8. Regular education and competency-based training programs should be developed for healthcare personnel involved in mechanical ventilation care. Training content should be updated according to emerging evidence and local epidemiological characteristics, and effectiveness should be evaluated through feedback and quality improvement processes24,262b9. Health care personnel in clinical departments using ventilators should receive professional training in ventilator operation and infection prevention and control25,262bAirway Management Procedures10. Healthcare personnel should adhere strictly to hand hygiene standards before and after ventilator-related procedures, including appropriate handwashing and hand antisepsis techniques, to reduce the risk of pathogen transmission24,262b11. Oral hygiene should be performed regularly, once every 6 to 8 hours16,28,302b12. Toothbrushing combined with rinsing is recommended for oral care in patients receiving mechanical ventilation; chlorhexidine solution should not be used routinely16,17,19,28,301a13. An endotracheal tube of appropriate size should be selected, and cuff pressure should be monitored and maintained at 25 to 30 cm H2O23,272b14. Continuous cuff pressure control devices should be used in combination with subglottic secretion drainage23,271a15. For patients expected to require endotracheal intubation for more than 72 hours, an endotracheal tube with subglottic secretion drainage should be selected23,25,272b16. Airway secretions should be suctioned promptly during patient transport, changes in body position or tube position, or accumulation of airway secretions, and aseptic technique should be followed12,25,292b17. Closed suction catheters are preferred for patients with infection or colonization caused by multidrug-resistant pathogens and for patients with suspected or confirmed respiratory infectious diseases22,26,342b18. Heated humidifiers or heat and moisture exchangers should be used in ventilator circuits. Continuous infusion of humidifying fluid by microinfusion pump should not be used for humidification, and sterile water should be used in heated humidifiers25,272b19. Water traps in ventilator circuits should be placed at the lowest point of the circuit, and the circuit should remain closed when condensate is removed. Condensate in the water trap should be removed before the patient is turned or repositioned25,26,332b20. For patients with suspected or confirmed respiratory infectious diseases, bacterial filters may be used at the expiratory limb of the ventilator to prevent contamination of internal tubing25,272bPositioning and Mobilization21. In the absence of contraindications, the head of the bed should be elevated to 30° to 45°13,25,27,332b22. Early mobilization should be encouraged and assisted in patients receiving mechanical ventilation, and rehabilitation training should be initiated as early as possible13,25,271cNutrition and Feeding23. When enteral nutrition is provided, the feeding route should be selected based on individualized assessment of aspiration risk, gastrointestinal function, expected duration of enteral feeding, and clinical feasibility11,15,18,332b24. Routine monitoring of gastric residual volume is not recommended for asymptomatic patients receiving enteral nutrition15,271c25. Routine stress ulcer prophylaxis is not recommended15,171aDevice and Equipment Management26. Indications for endotracheal intubation should be strictly assessed. Noninvasive ventilation should be preferred when appropriate. Oral endotracheal intubation is preferred, whereas nasal intubation is not recommended11,14,25,262b27. The need for continued mechanical ventilation and endotracheal intubation should be assessed daily, and weaning or extubation should be performed as early as possible11,252b28. Ventilator circuits should not be changed routinely or frequently in patients receiving continuous mechanical ventilation; circuits should be replaced promptly when contaminated or malfunctioning25,272b29. Heat and moisture exchangers should be replaced every 5 to 7 days and should be replaced promptly when contaminated or when airway resistance increases24,252b30. Reusable external ventilator circuits and accessories should be used for only 1 patient and disinfected after each use. For long-term use, they should be replaced weekly and centrally cleaned and disinfected by the central sterile supply department25,26,342b31. The ventilator exterior, buttons, panels, and other surfaces in use should be wiped and disinfected at least twice daily and immediately when contaminated. The frequency should be increased for patients with infection or colonization caused by multidrug-resistant organisms25,342bPharmacologic Prophylaxis and Decontamination32. Systemic or topical respiratory antimicrobial agents should be avoided for VAP prevention. Routine oral antimicrobial administration for selective digestive tract decontamination is not recommended13,18,20,27,312b33. For patients receiving sedatives, discontinuation or dose reduction should be assessed daily11,252b Summary of Best Evidence for the Prevention of Ventilator-Associated Pneumonia Discussion Compared with existing VAP prevention guidelines and bundle strategies, the contribution of this evidence summary lies not in proposing new preventive interventions, but in integrating and translating existing evidence into a structured nursing-oriented framework. Previous guidelines have provided important recommendations for VAP prevention; however, evidence from different sources is often dispersed across clinical guidelines, systematic reviews, and evidence summaries. By synthesizing evidence from multiple levels and organizing recommendations into eight practical domains, this study provides a more accessible framework to support bedside implementation and evidence-based nursing practice. Organizational Strategies and Evidence Implementation Evidence statements 1 to 5 first clarify that VAP prevention and control require a comprehensive and scientifically grounded management system. This responsibility should not rest solely with infection control departments but should involve coordinated efforts across hospital infection management, medical affairs, nursing, ICUs, respiratory medicine, laboratory medicine, and other disciplines. China’s first health industry standard specifically addressing the prevention and control of VAP, Standard for Prevention and Control of Ventilator-Associated Pneumonia (WS/T 863–2025), provides relevant specifications. The standard requires hospital administrative departments to formulate rules, regulations, and standard operating procedures and to allocate sufficient full-time infection prevention and control personnel to ensure implementation. In clinical practice, responsibilities should be clearly defined across disciplines, forming a closed loop of surveillance, early warning, and intervention. Nursing managers are responsible for compliance audits and staffing allocation; clinicians lead case diagnosis and treatment; infection control personnel and information engineers collaborate on targeted surveillance and data analysis with feedback; and isolation measures for multidrug-resistant organisms depend on timely reporting by the laboratory department and rapid responses from clinical staff.35 Evidence statements 6 to 9 indicate that the core of translating individual evidence statements into clinical practice is the establishment of a dynamic and iterative training mechanism. Training programs should integrate local microbiological data provided by epidemiologists and updated evidence from the latest literature evaluated by evidence-based methodology experts, thereby ensuring that training content is continuously optimized rather than static. The VAP bundle represents an integrated prevention framework requiring multidisciplinary coordination and standardized implementation. Within this framework, individual interventions should be translated into specific clinical responsibilities according to professional roles. Continuous education, competency assessment, and adherence monitoring are essential to maintain implementation quality. Meanwhile, bedside nursing practices, including hand hygiene, cuff pressure monitoring, and positioning management, remain critical components of daily VAP prevention. Toothbrushing-based oral care requires nursing implementation and professional guidance from dental specialists. Chen et al36 reported that, after implementation of bundled management in patients receiving mechanical ventilation, the incidence of VAP decreased from 25.79‰ to 12.95‰, in-hospital mortality decreased from 10.37% to 4.06%, and both the detection rate of multidrug-resistant organisms (12.77% vs 43.94%) and infection rate (0.52% vs 4.78%) were significantly reduced. In addition, Chen et al37 reported that, among older patients, the use of the plan-do-check-act cycle combined with bundled interventions not only reduced the incidence of VAP and shortened the duration of mechanical ventilation but also significantly reduced the number and timing of pressure injuries and alleviated their severity. These findings suggest that this combined management model has comprehensive value in improving multiple adverse outcomes among critically ill older patients. Therefore, in clinical practice, bundled implementation of multiple interventions may be more effective than single interventions in improving clinical outcomes. Nursing-Led Airway Management Interventions Evidence statements 10 to 20 mainly concern bedside interventions for VAP prevention that are performed frequently and involve multiple technical details. These measures focus on oral care, cuff management, and airway maintenance, forming an implementation model led primarily by nurses and respiratory therapists, with collaboration from physicians and pharmacists. Strict adherence to hand hygiene and aseptic technique is the fundamental requirement for all procedures. For oral care, the evidence specifies both frequency, every 6 to 8 hours, and method, toothbrushing combined with rinsing. In particular, the recommendation that chlorhexidine should not be used routinely represents an important shift and requires teams to reassess long-standing nursing routines. Clinical pharmacists should participate in evaluating the risk of mucosal irritation and antimicrobial resistance associated with chlorhexidine. Luo et al38 reported that oral care solution, care method, timing of the first oral care session, and frequency of care are key factors influencing oral care effectiveness, and that oral status is closely associated with the incidence of VAP. In addition, evidence recommends the combined use of toothbrushing, rinsing, and deep pharyngeal suctioning to prevent VAP. However, clinical implementation should also consider safety indicators, procedural complexity, and nursing workload. For cuff management, close collaboration between physicians and nurses is required. Continuous cuff pressure control combined with subglottic secretion drainage can effectively prevent microaspiration. Zhang et al39 improved the cuff pressure management process in patients with artificial airways and found that this intervention standardized cuff pressure monitoring and reduced clinical nursing risks. Respiratory therapists also play a key role in airway humidification, management of condensate in ventilator circuits, and installation of bacterial filters for patients with infectious diseases. Their professional expertise directly affects the safety of ventilator circuits. Positioning, Mobilization, and Nutrition Strategies Evidence statements 21 and 22 focus on reducing VAP risk through physical interventions. Elevating the head of the bed to 30°to 45°is a low-cost, high-yield foundational measure that should be implemented and accurately documented by nurses. Encouraging early mobilization and rehabilitation training requires a collaborative network in which intensivists assess the appropriate timing for initiation, rehabilitation therapists develop activity plans, and nurses provide monitoring. Although the level of evidence for this domain is relatively low, the overall value of early mobilization in shortening the duration of mechanical ventilation and improving prognosis has been widely recognized in rehabilitation medicine. This reflects a shift in VAP prevention from passive defense toward active health promotion. Evidence statements 23 to 25 involve the development of nutritional support strategies and medication management, requiring the joint participation of clinical nutritionists, pharmacists, and nurses. Nutritionists and physicians should select appropriate enteral access routes according to individual aspiration risk, gastrointestinal function, and expected duration of feeding. For mechanically ventilated patients, the choice between orogastric, nasogastric, and postpyloric feeding should be individualized based on clinical assessment and available evidence. During feeding implementation, nurses should no longer regard routine monitoring of gastric residual volume as the sole indicator of feeding intolerance; this update requires a shared change in team cognition. The recommendation against routine stress ulcer prophylaxis is a practice-changing evidence statement. It requires pharmacists and physicians to strictly evaluate indications for medication use and avoid excessive acid suppression, which may increase the risk of gastric bacterial colonization. This decision should be individualized according to the patient’s underlying diseases and current clinical condition, with careful consideration of benefits and risks. Device Management and Interventions Not Routinely Recommended Evidence statements 26 to 31 mainly address standardized management of ventilator-associated equipment. In VAP prevention, physicians and respiratory therapists should first jointly follow the principles of prioritizing noninvasive ventilation and conducting daily assessments of extubation readiness, thereby reducing the duration of invasive ventilation at the source. On this basis, the evidence specifies management parameters for ventilators and related accessories. Ventilator circuits should not be changed routinely or frequently, and heat and moisture exchangers should be replaced every 5 to 7 days to reduce unnecessary use of medical resources and contamination risk. For humidification device management, condensate generated within ventilator circuits during the use of heated humidifiers may become contaminated by the patient’s own airway microbiota. If not properly managed, contaminated condensate may flow directly into the lower respiratory tract and cause infection, or it may reflux into the humidification chamber and generate contaminated aerosols that can be inhaled. Therefore, condensate collection bottles should always be positioned at the lowest point of the circuit, kept upright, and emptied promptly. Humidification devices, closed suction systems, nebulizers, and other devices connected to the endotracheal tube also require appropriate disinfection and clearly defined replacement intervals. Regarding ventilator circuit replacement, Lorente et al40 reported that circuits need to be replaced only when visibly damaged or contaminated. For patients receiving long-term mechanical ventilation, weekly replacement of tubing is generally recommended; however, tubing should be replaced immediately if visible contamination or malfunction occurs. For closed suction systems, a systematic review by Huang et al22 found that closed suction was more effective than open suction in preventing VAP, shortening ICU length of stay, and reducing respiratory tract microbial colonization. However, a meta-analysis including 7 randomized clinical trials and 1098 patients showed that bacterial colonization at the suction catheter tip increased significantly after more than 72 hours of use, suggesting that the suction system should be replaced every 72 hours.41 Implementation of these device management standards depends heavily on standardized cleaning and disinfection of reusable devices by central sterile supply departments, as well as regular maintenance and disinfection of ventilators and related equipment by clinical engineers. These supporting processes collectively create an environmental safety barrier. Evidence statements 32 and 33 involve medication management and related nonpharmacologic measures. For antimicrobial stewardship, systemic or topical antimicrobial agents should not be used to prevent VAP, and routine oral antimicrobial administration for digestive tract decontamination should be avoided. Clinicians should strictly review indications to prevent inappropriate prophylactic antimicrobial use. Selective digestive tract decontamination (SDD) refers to the use of nonabsorbable antimicrobial agents in the oropharynx and gastrointestinal tract, with or without parenteral antibiotics. Selective oropharyngeal decontamination (SOD) refers to the application of topical antimicrobial agents only to the oropharynx. Given the potential increased risk of infection with antimicrobial-resistant organisms associated with SDD, SOD is preferred if a decontamination strategy is considered; however, it should still be implemented cautiously under antimicrobial stewardship principles. In addition, Meng et al42 reported that routine use of proton pump inhibitors (PPIs) for stress ulcer prophylaxis is not necessary in patients receiving mechanical ventilation. PPIs did not reduce the incidence of stress ulcers or VAP-related mortality and may even increase the risk of VAP. However, because the number of included studies was limited, large randomized clinical trials are still needed to further clarify the effect of stress ulcer prophylaxis on VAP. Limitations This study has several limitations. First, the quality of the synthesized recommendations depended on the methodological rigor and reporting quality of the available evidence resources. Second, because this study synthesized heterogeneous secondary evidence, including guidelines, systematic reviews, and evidence summaries, quantitative meta-analysis and statistical assessment of publication bias were not performed. Therefore, potential heterogeneity and publication bias should be considered when interpreting the findings. Third, the included evidence mainly focused on adult patients receiving mechanical ventilation in intensive care settings; therefore, the applicability of these recommendations to pediatric populations, specialized ICU populations, and healthcare systems with different resources requires further validation. Future Perspectives Future research should focus on several unresolved issues in VAP prevention. Although prevention bundles are widely recommended, the relative contribution of individual bundle components remains unclear. High-quality multicenter studies are needed to determine optimal intervention combinations and evaluate implementation strategies that improve adherence in different ICU settings. Further research should also explore nursing-led interventions and cost-effective approaches, particularly in resource-limited environments. Conclusions This evidence summary synthesized current evidence for VAP prevention and developed 33 recommendations across eight clinical domains. The findings highlight that effective VAP prevention requires integrated multidisciplinary strategies, including evidence-based bedside interventions, education, adherence monitoring, and quality improvement. By translating diverse evidence sources into a structured nursing-oriented framework, this study provides practical support for standardized VAP prevention practices and future implementation efforts. Further research is needed to determine the effectiveness and feasibility of these recommendations across different clinical settings.